kentucky semaglutide ileus legal team glp-1 in glp-1 ileus lawsuit in kentucky The lawsuits allege Novo Nordisk and Indianapolis-based Eli Lilly semaglutide ileus legal team in

More than 3 million people with Medicare could be eligible for the difficult-to-find and expensive weight-loss drug under new guidance which can cover the medication for patients who are obese or those who have a history of heart disease and are at risk of a heart attack or stroke

The most common side effects of Semaglutide are nausea, vomiting, diarrhea, and constipation

doi: 10.1016/j.toxicon.2017.11.003 100 QinJ.LiY.CaiZ.LiS.ZhuJ.ZhangF.et al

A study published last summer by JAMA Oncology looked at GLP-1 use and 14 obesity-related cancers and found that while the weight-loss drug lowered the risk of most cancers, there was a nonsignificant increased risk of kidney cancer particularly among people younger than 65

It's about managing the full picture